[go: up one dir, main page]

FR2984165B1 - TREATMENT OF MIGRAINE CRISES, INCLUDING FACE VASCULAR ALGIES - Google Patents

TREATMENT OF MIGRAINE CRISES, INCLUDING FACE VASCULAR ALGIES

Info

Publication number
FR2984165B1
FR2984165B1 FR1161863A FR1161863A FR2984165B1 FR 2984165 B1 FR2984165 B1 FR 2984165B1 FR 1161863 A FR1161863 A FR 1161863A FR 1161863 A FR1161863 A FR 1161863A FR 2984165 B1 FR2984165 B1 FR 2984165B1
Authority
FR
France
Prior art keywords
algies
crises
migraine
treatment
including face
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1161863A
Other languages
French (fr)
Other versions
FR2984165A1 (en
Inventor
Eric Belot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PHARMEURO
Original Assignee
PHARMEURO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PHARMEURO filed Critical PHARMEURO
Priority to FR1161863A priority Critical patent/FR2984165B1/en
Priority to EP12795785.0A priority patent/EP2790689A1/en
Priority to PCT/EP2012/073760 priority patent/WO2013087410A1/en
Publication of FR2984165A1 publication Critical patent/FR2984165A1/en
Application granted granted Critical
Publication of FR2984165B1 publication Critical patent/FR2984165B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR1161863A 2011-12-16 2011-12-16 TREATMENT OF MIGRAINE CRISES, INCLUDING FACE VASCULAR ALGIES Expired - Fee Related FR2984165B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR1161863A FR2984165B1 (en) 2011-12-16 2011-12-16 TREATMENT OF MIGRAINE CRISES, INCLUDING FACE VASCULAR ALGIES
EP12795785.0A EP2790689A1 (en) 2011-12-16 2012-11-27 Treatment of migraine headaches, in particular cluster headaches
PCT/EP2012/073760 WO2013087410A1 (en) 2011-12-16 2012-11-27 Treatment of migraine headaches, in particular cluster headaches

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1161863A FR2984165B1 (en) 2011-12-16 2011-12-16 TREATMENT OF MIGRAINE CRISES, INCLUDING FACE VASCULAR ALGIES

Publications (2)

Publication Number Publication Date
FR2984165A1 FR2984165A1 (en) 2013-06-21
FR2984165B1 true FR2984165B1 (en) 2014-06-27

Family

ID=47294877

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1161863A Expired - Fee Related FR2984165B1 (en) 2011-12-16 2011-12-16 TREATMENT OF MIGRAINE CRISES, INCLUDING FACE VASCULAR ALGIES

Country Status (3)

Country Link
EP (1) EP2790689A1 (en)
FR (1) FR2984165B1 (en)
WO (1) WO2013087410A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201992116A1 (en) * 2017-03-08 2020-01-29 СИНРКС ФАРМА, ЭлЭлСи PHARMACEUTICAL COMPOSITIONS OF FLOROGLUCINOL AND TRIMETHYLFLOROGLUCINOL

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1272562A (en) * 1968-09-17 1972-05-03 Orsymonde Pharmaceutical compositions comprising phloroglucinol ethers
FR2735025B1 (en) * 1995-06-12 1997-08-22 Fabre Pierre Sante THERAPEUTIC COMPOSITION CONTAINING A COMBINATION OF IBUPROFEN AND PHLOROGLUCINOL AND ITS USE AS ANTISPASMODE
JO3352B1 (en) * 2005-06-17 2019-03-13 Apr Applied Pharma Res Sa Diclofenac formulations and methods of use
FR2912654B1 (en) * 2007-02-19 2009-12-25 Rech En Toxicologie Et Pharmac DRUG ASSOCIATION COMPRISING PHLOROGLUCINOL AND PARACETAMOL
US20090264530A1 (en) * 2008-04-16 2009-10-22 Nickell Robert P Combined nsaid and acetaminophen formulation and method
IT1396649B1 (en) * 2009-12-04 2012-12-14 Diverdrugs Sl PHARMACEUTICAL PREPARATIONS INCLUDING FLOROGLUCINOL AND / OR ITS NON-STEROID ANTI-INFLAMMATORY DERIVATIVES AND DRUGS AND THEIR USE IN THE TREATMENT AND / OR PREVENTION OF THE PAIN SYNDROMES OF THE FEMALE GENITAL SYSTEM.

Also Published As

Publication number Publication date
EP2790689A1 (en) 2014-10-22
WO2013087410A1 (en) 2013-06-20
FR2984165A1 (en) 2013-06-21

Similar Documents

Publication Publication Date Title
LTC2785706I2 (en) SUBSTITUTED 4-PHENYL-PYRIDINES FOR THE TREATMENT OF NK-RECEPTOR-RELATED DISEASES
EP2672927A4 (en) EARLY APPENDIX OCCLUSION AND TREATMENT OF ARRHYTHMIA
EP2529355A4 (en) CORRELATION OF VOICE-BODY IDENTITY
EA201491028A1 (en) METHOD OF OBTAINING SUBSTITUTED 5-FLUOR-1H-PYRAZOLOPIRIDINES
EP2723384A4 (en) TREATMENT OF PROTEINEOPATHIES
EA201500362A1 (en) RHO-KINASE INHIBITORS
EP2670434A4 (en) TREATMENT OF TAUOPATHIA
IL228538A0 (en) Methods to increase the effectiveness of cancer treatment 1folr
EP2585075A4 (en) METHODS OF TREATING SOPHAGEAL INFLAMMATION
PL2523661T3 (en) NKCC inhibitors for the treatment of autism
EP2512240A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF TRIGEMINO-AUTONOMIC CEPHALES, MIGRAINS AND VASCULAR DISEASES
SMT201400106B (en) Met inhibitors to increase the effectiveness of radiotherapy
BR112013018898A2 (en) treatment of autism spectrum disorders employing glycyl-1-2-methylprolyl-1-glutamic acid.
EP2536468A4 (en) TREATMENT OF CHRONIC INFLAMMATORY DISEASES
HRP20182043T1 (en) THE USE OF ANTI-CONFESSIONAL MEDICINES TO IMPROVE THE THERAPEUTIC EFFECT OF ACETYLCHOLINESTERASE INHIBITOR
EP2786738A4 (en) HAIR TREATMENT AGENT COMPOSITION
EP2800575A4 (en) TREATMENT OF SUBARACHNOID HEMORRHAGIA AND ISCHEMIA
EP2718255A4 (en) CHINONIC COMPOUNDS FOR THE TREATMENT OF APE1-MEDIATED DISEASES
PL2718434T3 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF CARDIOUS DISEASE
EP2750709A4 (en) TREATMENT OF CACHEXIE
EP2616186A4 (en) TREATMENT OF WOOD CHIPS
EP2582391A4 (en) TREATMENT OF ARTHRITIS
EP2903643A4 (en) TREATMENT OF PSYCHIATRIC DISORDERS
EP2673363A4 (en) TREATMENT OF ANGIOGENESIS DISORDERS
UA107346C2 (en) Use of nifuratel to treat infections caused by atopobium species

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20160831